We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA’s GCP Working Group Outlines Inspection Priorities
EMA’s GCP Working Group Outlines Inspection Priorities
The European Medicines Agency’s working group on good clinical practices and inspections outlined its goals for 2017, including plans to prioritize certain site inspections.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor